Psychological distress and lifestyle disruption in low-risk prostate cancer patients: Comparison between active surveillance and radical prostatectomy

Objective: To quantify distress in men treated with radical prostatectomy (RP) or active surveillance (AS). Methods: In a retrospective cross-sectional design, we assessed men through questionnaire and investigator-designed questions. Results: RP patients worried more about cancer spread than AS pat...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychosocial oncology 2018-03, Vol.36 (2), p.159-174
Main Authors: Matthew, Andrew G., Raz, Orit, Currie, Kristen L., Louis, Alyssa S., Jiang, Haiyan, Davidson, Tal, Fleshner, Neil E., Finelli, Antonio, Trachtenberg, John
Format: Article
Language:English
Subjects:
active surveillance
Aged
Aged, 80 and over
Cancer
Cancer surgery
Cross-Sectional Studies
Decision Making
Health problems
Humans
illness intrusiveness
Life Change Events
Lifestyles
Male
Men
Middle Aged
Patients
Prostate cancer
Prostatectomy - psychology
Prostatic Neoplasms - psychology
Prostatic Neoplasms - therapy
Psychological distress
radical prostatectomy
Retrospective Studies
Risk Assessment
Stress, Psychological - epidemiology
Surveillance
Surveys and Questionnaires
treatment decision
Urological surgery
Watchful Waiting
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: To quantify distress in men treated with radical prostatectomy (RP) or active surveillance (AS). Methods: In a retrospective cross-sectional design, we assessed men through questionnaire and investigator-designed questions. Results: RP patients worried more about cancer spread than AS patients. RP patients were influenced by friends for treatment decision, whereas AS patients were influenced by urologists. RP group report declines in intimacy and instrumental. AS men worried more about future health and dying than post-RP men. Conclusion: Fear of disease progression may be a motivating factor in choosing RP. AS patients adhere to their treatment decision in spite of distress.
ISSN:0734-7332
1540-7586
DOI:10.1080/07347332.2017.1342733